Works matching IS 22974725 AND DT 2016 AND VI 32 AND IP 5
Results: 23
Meetings and Conferences.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 382, doi. 10.1159/000452112
- Publication type:
- Article
Darmsonographie ermöglicht patientenfreundliches Verlaufsmonitoring bei CED.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 381
- Publication type:
- Article
Aktuelle Behandlungsoptionen für Patienten mit metastasiertem kolorektalem Karzinom.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 381
- By:
- Publication type:
- Article
Wissenschaftliches Symposium behandelt Gastro-Themen der Zukunft.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 380
- Publication type:
- Article
Biosimilar Inflectra™ bewährt sich als wirksame und verträgliche Therapiealternative bei CED.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 380
- Publication type:
- Article
Rezidivierendes akutes Abdomen? An ungewöhnliche Auslöser denken!
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 379
- Publication type:
- Article
Teduglutid auch für Kinder und Jugendliche.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 379
- By:
- Publication type:
- Article
Hausärzte bei der Behandlung der CDAD immer mehr gefragt: Aktuelle Zahlen bestätigen den Trend im ambulanten Bereich erneut.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 378
- Publication type:
- Article
EU-Zulassung für Elbasvir/Grazoprevir.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 378
- Publication type:
- Article
Patienten leiden unter ungenügender Abstimmung.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 378
- Publication type:
- Article
Aktuelle «Real-Life»-Studien zum ersten Infliximab-Biosimilar (Remsima®) geben Behandlungssicherheit bei CED.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 377
- Publication type:
- Article
Neue Therapieoption für vorbehandelte Patienten.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 376
- Publication type:
- Article
Erstes einmal tägliches Single-Tablet-Regime gegen alle Genotypen der Hepatitis C.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 375
- Publication type:
- Article
Esophagus-Related Symptoms in First-Degree Relatives of Patients with Achalasia: Is Screening Necessary?
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 369, doi. 10.1159/000445790
- By:
- Publication type:
- Article
Metabolic Syndrome: An Interdisciplinary Approach.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 363, doi. 10.1159/000452140
- Publication type:
- Article
Metabolic Syndrome in Children and Adolescents.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 357, doi. 10.1159/000449268
- By:
- Publication type:
- Article
Surgical Treatment of Metabolic Syndrome.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 352, doi. 10.1159/000449110
- By:
- Publication type:
- Article
Pharmacological Interventions against Obesity: Current Status and Future Directions.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 347, doi. 10.1159/000450904
- By:
- Publication type:
- Article
Weight Management in Primary Care.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 342, doi. 10.1159/000450667
- By:
- Publication type:
- Article
Clinical Scenario of the Metabolic Syndrome.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 336, doi. 10.1159/000449028
- By:
- Publication type:
- Article
Non-Alcoholic Fatty Liver Disease: Cause or Effect of Metabolic Syndrome.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 329, doi. 10.1159/000448940
- By:
- Publication type:
- Article
Metabolic Vascular Syndrome: New Insights into a Multidimensional Network of Risk Factors and Diseases.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 319, doi. 10.1159/000450866
- By:
- Publication type:
- Article
Metabolic Syndrome: An Interdisciplinary Approach.
- Published in:
- Visceral Medicine, 2016, v. 32, n. 5, p. 316, doi. 10.1159/000452431
- By:
- Publication type:
- Article